Epidemiology, Antifungal Resistance and Therapy in Fungal Infection
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 31 October 2024 | Viewed by 1249
Special Issue Editors
Interests: antifungal resistance; taxonomy; phylogeny
Special Issues, Collections and Topics in MDPI journals
Interests: epidemiology; antifungal resistance; yeast infections; candidemia
Interests: dermatophyte infection; invasive candida infection; antifungal susceptibility; antimicrobial activity of plant-drived products
Special Issue Information
Dear Colleagues,
Fungal infections have been increasing globally. Many of them are becoming a serious threat to human life, either because of intrinsic resistance, acquired resistance, difficult access to mycological diagnosis or lack of knowledge of the aetiological agents in a given region. Several of the above-mentioned factors were taken into account to elaborate the WHO list of fungal pathogens of importance published in 2022. This list classified fungi into critical, high and medium priority. Given the above, we believe it is important to provide data on the epidemiology and antifungal resistance/therapy on a global level. Hence, we cordially invite you all to contribute your articles to this Special Issue.
Dr. Eduardo Alvarez Duarte
Dr. Valentina Salas
Prof. Dr. Paulo Murilo Neufeld
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epidemiology
- antifungal agents
- antifungal treatment
- echinocandins
- fluconazole
- fungemia
- microsatellite genotyping
- yeast
- antifungal resistance
- aspergillosis
- azole
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
